Colchicine ameliorates the chronic inflammatory state in patients with chronic rheumatic valvular heart disease: a pilot study.

Egypt Heart J · 2020 · PMC7364777 · PMID 32676868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

On looking at our results, patients showed highly significant reduction in the serum inflammatory markers after 1 month of receiving colchicine 0.5 mg twice daily on regular basis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.